Deviations in human gut microbiota: A novel diagnostic test for determining dysbiosis in patients with IBS or IBD

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 1, 2015, Pages 71-83

  Casen C ^a   Vebo H C ^a   Sekelja, M ^a   Hegge, F T ^a   Karlsson, M K ^a   Ciemniejewska, E ^a   Dzankovic, S ^a   Froyland C ^a   Nestestog, R ^a   Engstrand, L ^b   Munkholm, P ^c   Nielsen, O H ^c   Rogler, G ^d   Simren M ^e   Ohman L ^e   Vatn, M H ^f,g   Rudi, K ^h  

^a Genetic Analysis AS   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITY OF OSLO   (Norway)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACTERIA; ADOLESCENT; ADULT; AGED; ANALYZER; ARTICLE; BACTEROIDETES; COMPUTER MODEL; CONTROLLED STUDY; CROHN DISEASE; DEEP SEQUENCING; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA PROBE; DYSBIOSIS; FECES ANALYSIS; FEMALE; FIRMICUTES; GA MAP DYSBIOSIS TEST; HUMAN; IN VITRO STUDY; INFLAMMATORY BOWEL DISEASE; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; INTESTINE FLORA; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MOLLICUTES; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEOBACTERIA; REMISSION; SEQUENCE ANALYSIS; ULCERATIVE COLITIS; VERRUCOMICROBIA; BACTERIUM; DIAGNOSTIC TEST; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NORWAY; PROCEDURES; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BACTERIA; DIAGNOSTIC TESTS, ROUTINE; DYSBIOSIS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; NORWAY; YOUNG ADULT;

EID: 84930486219     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13236     Document Type: Article

References (40)

1. Arumugam M, Raes J, Pelletier E, et al,. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80.
2. Sekelja M, Berget I, Naes T, Rudi K,. Unveiling an abundant core microbiota in the human adult colon by a phylogroup-independent searching approach. ISME J 2011; 5: 519-31.
3. Ding T, Schloss PD,. Dynamics and associations of microbial community types across the human body. Nature 2014; 509: 357-60.
4. Ley RE, Turnbaugh PJ, Klein S, Gordon JI,. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-3.
5. Manichanh C, Rigottier-Gois L, Bonnaud E, et al,. Reduced diversity of faecal microbiota in Cohn's disease revealed by a metagenomic approach. Gut 2006; 55: 205-11.
6. Larsen N, Vogensen FK, van den Berg FW, et al,. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010; 5: e9085.
7. Kostic AD, Xavier RJ, Gevers D,. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014; 146: 1489-99.
8. Hong SN, Rhee PL,. Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol 2014; 20: 2470-81.
9. Gasbarrini A, Corazza GR, Gasbarrini G, et al,. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009; 29 (Suppl 1): 1-49.
10. Sekirov I, Russell SL, Antunes LC, Finlay BB,. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904.
11. Simren M, Barbara G, Flint HJ, et al,. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159-76.
12. Ford AC, Spiegel BM, Talley NJ, Moayyedi P,. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7: 1279-86.
13. Salonen A, de Vos WM, Palva A,. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010; 156: 3205-15.
14. Vanner S,. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment. Gut 2008; 57: 1315-21.
15. Budding AE, Grasman ME, Lin F, et al,. IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J 2010; 24: 4556-64.
16. Thorkildsen LT, Nwosu FC, Avershina E, et al,. Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients. Gastroenterol Res Pract 2013; 2013: 636785.
17. Rajca S, Grondin V, Louis E, et al,. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Cohn's disease. Inflamm Bowel Dis 2014; 20: 978-86.
18. Kelly CP,. Fecal microbiota transplantation-an old therapy comes of age. N Engl J Med 2013; 368: 474-5.
19. Pedersen N, Vegh Z, Burisch J, et al,. Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol 2014; 20: 6680-4.
20. Pedersen N, Vinding K, Vegh Z, et al,. Gut microbiota in IBD patients with IBS before and after 6 weeks of low FODMAP diet. Gastroenterology 2014; 146: S-241.
21. Macfarlane S, Cleary S, Bahrami B, Reynolds N, Macfarlane GT,. Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment Pharmacol Ther 2013; 38: 804-16.
22. Vebø HC, Sekelja M, Nestestog R, et al,. Temporal development of the infant gut microbiota in immunoglobulin E-sensitized and nonsensitized children determined by the GA-map infant array. Clin Vaccine Immunol 2011; 18: 1326-35.
23. Sugimoto N, Katoh M, Nakano S, Ohmichi T, Sasaki M,. RNA/DNA hybrid duplexes with identical nearest-neighbor base-pairs have identical stability. FEBS Lett 1994; 354: 74-8.
24. Mardia KV, Kent JT, Bibby JM,. Multivariate Analysis. London: Academic Press, 1979.
25. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1998L0079:20090807:en:PDF.
26. Langsrud Ø,. 50-50 multivariate analysis of variance for collinear responses. J R Stat Soc Ser D 2002; 51: 305-17.
27. Naseribafrouei A, Hestad K, Avershina E, et al,. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 2014; 26: 1155-62.
28. Lozupone CA, Knight R,. Species divergence and the measurement of microbial diversity. FEMS Microbiol Rev 2008; 32: 557-78.
29. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: the R Foundation for Statistical Computing. Available at: http://www.R-project.org/.
30. Jeffery IB, O'Toole PW, Ohman L, et al,. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61: 997-1006.
31. Faith JJ, Guruge JL, Charbonneau M, et al,. The long-term stability of the human gut microbiota. Science 2013; 341: 1237439.
32. Aravindraja C, Viszwapriya D, Karutha PS,. Ultradeep 16S rRNA sequencing analysis of geographically similar but diverse unexplored marine samples reveal varied bacterial community composition. PLoS ONE 2013; 8: e76724.
33. Collins SM,. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 2014; 11: 497-505.
34. Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis DG,. Current insights in to the pathophysiology of irritable bowel syndrome. Gut Pathog 2010; 2: 3.
35. Dupont HL,. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther 2014; 39: 1033-42.
36. Machiels K, Joossens M, Sabino J, et al,. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014; 63: 1275-83.
37. Dinan TG, Cryan JF,. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 2013; 25: 713-9.
38. Finegold SM, Dowd SE, Gontcharova V, et al,. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010; 16: 444-53.
39. Sha S, Liang J, Chen M, et al,. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther 2014; 39: 1003-32.
40. Mizrahi-Man O, Davenport ER, Gilad Y,. Taxonomic classification of bacterial 16S rRNA genes using short sequencing reads: evaluation of effective study designs. PLoS ONE 2013; 8: e53608.